Improving Aspirin Use Among Adults at Risk for Cardiovascular Disease (CVD)

Completed · Not applicable

Conditions studied: Cardiovascular Disease

In brief

The investigators' aim is to implement an intervention to increase aspirin prophylaxis use among patients that is patient initiated, optimizes use of physician and staff time, appropriately compensates staff, provides clinicians with tools necessary for managing aspiring prophylaxis, and ensures continuous management.

Key facts

Study ID

NCT00981032

Run by

Geisinger Clinic

People needed

884

Starts

2009-10-01

Expected to finish

2010-07-01

Last updated by the study team

2011-02-17

Who can join

Age: 45 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with an appointment in the Geisinger clinic who:
• are between the ages of 45-70 (male) or 50-70 (female), and
• have one of the following risk factors:
• Smoke
• Direct LDL > 160 mg/dl
• HDL < 45 mg/dl (males) HDL < 35 mg/dl (females)
• Diabetes diagnosis
• Hypertension diagnosis
• CAD diagnosis

You may not qualify if…

• > 70 years
• Stomach Ulcer History
• Aspirin Allergy
• Anti-coagulation Therapy History
• Clotting Disorder Diagnosis
• Hypersensitivity to non-steroidal anti-inflammatory agents such as Ibuprofen, Aleve, or Motrin
• Hemorrhagic Stroke History
• Current Aspirin use
• 1st Outpatient Visit

Where it is running

• Geisinger Clinic - Lewistown — Lewistown, Pennsylvania, United States
• Geisinger Clinic - Moshannon Valley — Philipsburg, Pennsylvania, United States
• Geisinger Clinic - Lake Scranton — Scranton, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.